Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Eledon prepares to reveal critical Phase 2 tegoprubart findings at ASN Kidney Week 2025 — a potential transplant game-changer Find out how Eledon’s tegoprubart Phase 2 BESTOW trial debut at ASN 2025 could reshape kidney transplant immunosuppression strategies — read more. bySoujanya RaviOctober 17, 2025